<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05006638</url>
  </required_header>
  <id_info>
    <org_study_id>MD27/2021</org_study_id>
    <nct_id>NCT05006638</nct_id>
  </id_info>
  <brief_title>Assessing The Role Of Intravenous Lipid Emulsion As A Life Saving Therapy In Pesticides Toxicity</brief_title>
  <official_title>Assessing The Role Of Intravenous Lipid Emulsion As A Life Saving Therapy In Pesticides Toxicity: A Randomized Controlled Trial In Poison Control Center Of Ain Shams University Hospitals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aya Sabry Mohamed Mohamed</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intravenous lipid emulsion is an established, effective treatment for local anesthetic&#xD;
      systemic toxicity. It is also efficacious in animal models of severe cardiotoxicity caused by&#xD;
      a number of other medications. Recent case reports of successful resuscitation suggest the&#xD;
      efficacy of lipid emulsion infusion for treating non-local anesthetic overdoses across a wide&#xD;
      spectrum of drugs. The present study will focus on the potential role of intravenous lipid&#xD;
      emulsion as an adjuvant therapy in pesticides toxicity.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mortality rate reduction</measure>
    <time_frame>1 year</time_frame>
    <description>the primary end point is to lower the mortality rate for patients poisoned with pesticides</description>
  </primary_outcome>
  <primary_outcome>
    <measure>organ damage reduction</measure>
    <time_frame>1 year</time_frame>
    <description>another primary end point is to reduce organ damage and injury for survivors</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Pesticide Poisoning</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>will receive the traditional supportive treatment according to (PCC-ASUH) protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>case group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>will receive the traditional supportive treatment plus administration of ILE (20%) 1.5 ml/kg as a bolus over 2-3 minutes. Followed immediately by an infusion of 20 % lipid emulsion at a rate of 0.25 mL/kg/min. After 3 minutes of this infusion rate, response to the bolus and initial infusion should be assessed. If there has been a significant response, the infusion rate can be adjusted to 0.025 mL/kg/min with monitoring of blood pressure, heart rate, and other available hemodynamic parameters during the infusion with a maximum dose of 10 mL/kg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lipid Emulsion, Intravenous</intervention_name>
    <description>Lipid emulsion is a mixture of soybean oil, egg phospholipids, glycerine, and is available in 10%, 20%, and 30% strengths. It has been used for decades as parenteral nutrition and for caloric supplementation and essential fatty acid deficiency. It has also been used as a carrier for lipid soluble medications</description>
    <arm_group_label>case group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Atropine</intervention_name>
    <description>a drug used as an antidote for some types of pesticides</description>
    <arm_group_label>case group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Toxogonin</intervention_name>
    <description>a drug used as an antidote for some types of pesticides</description>
    <arm_group_label>case group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Bicarbonate Powder and ondansetron</intervention_name>
    <description>standard of care for treatment of aluminuim phosphide is provided for patients poisoned with aluminuim phosphide</description>
    <arm_group_label>case group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with acute pesticide intoxications with poison severity score 2 or 3 admitted&#xD;
             in ICU of PCC-ASUH&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients less than 18 years and more than 65 years.&#xD;
&#xD;
          -  Pregnant and lactating females.&#xD;
&#xD;
          -  Presence of medical diseases (e.g. renal, hepatic, cardiovascular, neurological&#xD;
             diseases and chronic pancreatitis.)&#xD;
&#xD;
          -  Allergy to soya-, egg-or peanut protein&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Aya Sabry Mohamed</last_name>
    <phone>+201013910938</phone>
    <email>dr.ayasabry@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Poison Control Center of Ain-Shams University hospitals</name>
      <address>
        <city>Cairo</city>
        <state>Abbasya</state>
        <zip>11311</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aya Sabry Mohamed</last_name>
      <phone>+201013910938</phone>
      <email>dr.ayasabry@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 8, 2021</study_first_submitted>
  <study_first_submitted_qc>August 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 16, 2021</study_first_posted>
  <last_update_submitted>August 8, 2021</last_update_submitted>
  <last_update_submitted_qc>August 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Aya Sabry Mohamed Mohamed</investigator_full_name>
    <investigator_title>Assistant lecturer of forensic medicine and clinical toxicology department faculty of medicine Ain shams university</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Poisoning</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atropine</mesh_term>
    <mesh_term>Ondansetron</mesh_term>
    <mesh_term>Fat Emulsions, Intravenous</mesh_term>
    <mesh_term>Obidoxime Chloride</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

